Emcure Pharmaceuticals (Emcure Pharma) IPO subscription standing began on Wednesday July 3, 2024 and can shut on July 5, 2024. Emcure Pharmaceuticals (Emcure Pharma) IPO to lift round ₹1952.03 crores by way of IPO. The retail quota is 35%, QIB is 50% and NII is 15%. The worth band is fastened at ₹960 to ₹1008 in step with fairness proportion.
– Source : IPOWATCH
